Literature DB >> 32185699

Structural Basis of a Conventional Recognition Mode of IGHV1-69 Rheumatoid Factors.

Mitsunori Shiroishi1.   

Abstract

Rheumatoid factors (RFs) are autoantibodies that recognize the fragment crystallizable (Fc) region of immunoglobulin G (IgG). Genetically diverse RFs are produced in rheumatoid arthritis patients; however, in hematologic diseases, such as cryoglobulinemia and B cell lymphoma, RFs from a limited combination of heavy chain V-region genes and J-region genes are produced in large quantities and forms immune complexes with IgG. These genetically limited RFs have historically been used for the immunochemical characterization of RFs. Among them, RFs derived from the heavy-chain germline gene IGHV1-69 are the most common. Recently, the crystal structure of an IGHV1-69-derived RF named YES8c was elucidated in complex with human IgG1-Fc. Based on the structure and mutant analyses, a recognition mechanism for the autoantigen (IgG-Fc) common to IGHV1-69-derived RFs was proposed. This review summarizes the immunochemical character of the IGHV1-69-derived RFs, and then focuses on the recognition mechanism of the IGHV1-69-derived RFs, referring the structural features of the IGHV1-69-derived neutralizing antibodies.

Entities:  

Keywords:  Autoantibody; B cell lymphoma; Cryoglobulinemia; Crystal structure; Immunoglobulin-G (IgG); Molecular recognition; Rheumatoid factor

Mesh:

Substances:

Year:  2021        PMID: 32185699     DOI: 10.1007/5584_2020_510

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  36 in total

1.  Identification of a novel stereotypic IGHV4-59/IGHJ5-encoded B-cell receptor subset expressed by various B-cell lymphomas with high affinity rheumatoid factor activity.

Authors:  Richard J Bende; Jerry Janssen; Thera A M Wormhoudt; Koen Wagner; Jeroen E J Guikema; Carel J M van Noesel
Journal:  Haematologica       Date:  2016-02-08       Impact factor: 9.941

2.  Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome.

Authors:  Richard J Bende; Linda M Slot; Robbert Hoogeboom; Thera A M Wormhoudt; Akanbi O Adeoye; Jeroen E J Guikema; Carel J M van Noesel
Journal:  Arthritis Rheumatol       Date:  2015-04       Impact factor: 10.995

3.  Molecular analysis of IgM rheumatoid factor binding to chimeric IgG.

Authors:  S E Artandi; S M Canfield; M H Tao; K L Calame; S L Morrison; V R Bonagura
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

4.  Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.

Authors:  Valli De Re; Salvatore De Vita; Daniela Gasparotto; Alessandra Marzotto; Antonino Carbone; Gianfranco Ferraccioli; Mauro Boiocchi
Journal:  Eur J Immunol       Date:  2002-03       Impact factor: 5.532

5.  A role for hepatitis C virus infection in type II cryoglobulinemia.

Authors:  V Agnello; R T Chung; L M Kaplan
Journal:  N Engl J Med       Date:  1992-11-19       Impact factor: 91.245

6.  Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors.

Authors:  V R Bonagura; S E Artandi; A Davidson; I Randen; N Agostino; K Thompson; J B Natvig; S L Morrison
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

7.  Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia.

Authors:  Edgar D Charles; Rashidah M Green; Svetlana Marukian; Andrew H Talal; Gerond V Lake-Bakaar; Ira M Jacobson; Charles M Rice; Lynn B Dustin
Journal:  Blood       Date:  2007-10-17       Impact factor: 22.113

8.  Somatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemia.

Authors:  Edgar D Charles; Michael I M Orloff; Eiko Nishiuchi; Svetlana Marukian; Charles M Rice; Lynn B Dustin
Journal:  Arthritis Rheum       Date:  2013-09

9.  Structural restriction in the heavy chain CDR3 of human rheumatoid factors.

Authors:  M Børretzen; I Randen; J B Natvig; K M Thompson
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

10.  Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity.

Authors:  Richard J Bende; Wilhelmina M Aarts; Robert G Riedl; Daphne de Jong; Steven T Pals; Carel J M van Noesel
Journal:  J Exp Med       Date:  2005-04-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.